Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDH17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM134A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00869 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARIH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM160B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC34A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAZAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100272217 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on